i am a physician

insurance coverage

Have questions on insurance coverage? We have information and answers to questions about Sonablate® HIFU coverage.

insurance coverage

Worried about your prostate disease? Afraid of major prostate surgery and painful symptoms?

patient information


Traditional Medicare carriers do not require prior authorization for the High Intensity Focused Ultrasound (HIFU) procedure.

Commercial & Medicare Advantage Plans

Many commercial insurance plans cover HIFU on a case-by-case basis. Prior authorization is recommended for all HIFU procedures. Contact your health plan to understand their prior authorization requirements before initiating treatment.
To assist your provider in the prior authorization process, Sonablate Corp. has sample letters of medical necessity (LOMN) and other supporting literature available. These documents are examples and should be customized to your specific clinical case by your physician. These documents will provide an example of the types of information and documentation required by health plans to determine coverage for the HIFU procedure. These sample documents are available in the Support Documents section. Always submit your prior authorization request in accordance with your health plan's process.

Private, Commercial Health Plans

Each private insurance plan will determine CPT or HCPCS code requirements for hospital outpatient or Ambulatory Surgery Center System claims. Whether billing CPT or HCPCS codes, private commercial health plans have proprietary facility fee schedules that may be based on a percentage of Medicare rates or negotiated contracts.

Denials & Appeals

If your prior authorization is denied, you have the right to appeal and should refer to your specific health plan for their appeal process. Your provider can appeal all denials on your behalf.
Sonablate Corp. has also developed a sample appeal letter that will assist your physician with your appeal letter development. The sample letters and other supporting documentation can be found in the Support Documents section.
Whether you receive a prior authorization denial, claim denial or insufficient payment, your physician can appeal on your behalf. The appeal process ensures that critical patient treatment decisions are given appropriate consideration. When appealing, please refer to and follow your health plan's defined appeal process.
Denials may be the result of the health plan not understanding the HIFU technology, or the submission requires additional information to help the health plan review your case. The health plan will review a variety of information, including medical records, published data and societal support. Your provider should always submit your appeal in accordance with the health plan's appeal timeline and process.
For additional guidance contact the Sonablate Reimbursement Team.

Sonablate® HIFU is approved in more than 50 countries worldwide and was the first focused ultrasound device to be FDA-cleared in the U.S. for the ablation of prostate tissue. This innovative solution for prostate diseases has allowed Sonablate® HIFU to become the industry leader in focal therapy. Sonablate is a non-invasive device intended for precise planning and monitoring of ultrasound imaging and high intensity focused ultrasound to ablate prostate tissue. Most common side effects include pain and discomfort and urinary tract infection (UTI). Rare side effects include rectal injury, which may require intervention. Consult your physician to see if the Sonablate procedure is right for you.

© 2023 Sonablate Corp. All Rights Reserved.